128 related articles for article (PubMed ID: 31883490)
1. A 18β-glycyrrhetinic acid conjugate with Vorinostat degrades HDAC3 and HDAC6 with improved antitumor effects.
Huang M; Xie X; Gong P; Wei Y; Du H; Xu Y; Xu Q; Jing Y; Zhao L
Eur J Med Chem; 2020 Feb; 188():111991. PubMed ID: 31883490
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor effects of novel 18β-glycyrrhetinic acid derivatives featuring an exocyclic α,β-unsaturated carbonyl moiety in ring A.
Huang M; Gong P; Wang Y; Xie X; Ma Z; Xu Q; Liu D; Jing Y; Zhao L
Bioorg Chem; 2020 Oct; 103():104187. PubMed ID: 32890994
[TBL] [Abstract][Full Text] [Related]
3. HDAC and Ku70 axis- an effective target for apoptosis induction by a new 2-cyano-3-oxo-1,9-dien glycyrrhetinic acid analogue.
Gong P; Li K; Li Y; Liu D; Zhao L; Jing Y
Cell Death Dis; 2018 May; 9(6):623. PubMed ID: 29795376
[TBL] [Abstract][Full Text] [Related]
4. Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.
Chintharlapalli S; Papineni S; Jutooru I; McAlees A; Safe S
Mol Cancer Ther; 2007 May; 6(5):1588-98. PubMed ID: 17513608
[TBL] [Abstract][Full Text] [Related]
5. Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells.
Papineni S; Chintharlapalli S; Safe S
Mol Pharmacol; 2008 Feb; 73(2):553-65. PubMed ID: 17989348
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
Chintharlapalli S; Papineni S; Abdelrahim M; Abudayyeh A; Jutooru I; Chadalapaka G; Wu F; Mertens-Talcott S; Vanderlaag K; Cho SD; Smith R; Safe S
Int J Cancer; 2009 Oct; 125(8):1965-74. PubMed ID: 19582879
[TBL] [Abstract][Full Text] [Related]
7. Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor.
Pang X; Zhang L; Wu Y; Lin L; Li J; Qu W; Safe S; Liu M
J Pharmacol Exp Ther; 2010 Oct; 335(1):172-9. PubMed ID: 20631299
[TBL] [Abstract][Full Text] [Related]
8. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of methyl 2-cyano-3,12-dioxo-18β-olean-1,9(11)-dien-30-oate analogues to determine the active groups for inhibiting cell growth and inducing apoptosis in leukemia cells.
Li X; Wang Y; Gao Y; Li L; Guo X; Liu D; Jing Y; Zhao L
Org Biomol Chem; 2014 Sep; 12(34):6706-16. PubMed ID: 25033318
[TBL] [Abstract][Full Text] [Related]
10. CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen species.
Takeuchi H; Taoka R; Mmeje CO; Jinesh GG; Safe S; Kamat AM
Urol Oncol; 2016 Aug; 34(8):337.e11-8. PubMed ID: 27038699
[TBL] [Abstract][Full Text] [Related]
11. The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.
Negmeldin AT; Pflum MKH
Bioorg Med Chem Lett; 2017 Aug; 27(15):3254-3258. PubMed ID: 28648461
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative.
Jutooru I; Chadalapaka G; Chintharlapalli S; Papineni S; Safe S
Mol Carcinog; 2009 Aug; 48(8):692-702. PubMed ID: 19125423
[TBL] [Abstract][Full Text] [Related]
13. 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines.
Lee CS; Yang JC; Kim YJ; Jang ER; Kim W; Myung SC
Eur J Pharmacol; 2010 Dec; 649(1-3):354-61. PubMed ID: 20868669
[TBL] [Abstract][Full Text] [Related]
14. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
[TBL] [Abstract][Full Text] [Related]
15. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
You BR; Han BR; Park WH
Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity.
Gao C; Dai FJ; Cui HW; Peng SH; He Y; Wang X; Yi ZF; Qiu WW
Chem Biol Drug Des; 2014 Aug; 84(2):223-33. PubMed ID: 24612785
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of c-FLIP, XIAP and Mcl-1 protein as well as depletion of reduced glutathione contribute to the apoptosis induction of glycyrrhetinic acid derivatives in leukemia cells.
Song D; Gao Y; Wang R; Liu D; Zhao L; Jing Y
Cancer Biol Ther; 2010 Jan; 9(2):96-108. PubMed ID: 19949310
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of triazole linked glycosylated 18β-glycyrrhetinic acid derivatives as anticancer agents.
Parida PK; Sau A; Ghosh T; Jana K; Biswas K; Raha S; Misra AK
Bioorg Med Chem Lett; 2014 Aug; 24(16):3865-8. PubMed ID: 25027936
[TBL] [Abstract][Full Text] [Related]
19. An Endogenous Reactive Oxygen Species (ROS)-Activated Histone Deacetylase Inhibitor Prodrug for Cancer Chemotherapy.
Bhagat SD; Singh U; Mishra RK; Srivastava A
ChemMedChem; 2018 Oct; 13(19):2073-2079. PubMed ID: 30070768
[TBL] [Abstract][Full Text] [Related]
20. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
Lee CS; Kim YJ; Lee MS; Han ES; Lee SJ
Life Sci; 2008 Sep; 83(13-14):481-9. PubMed ID: 18721818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
